Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Researchers have found that a repurposed anti-inflammatory and anti-allergic drug previously developed for asthma improved blood glucose control in people with type 2 diabetes and non-alcoholic fatty liver disease.

Patients who received the asthma drug amlexanox had a significantly greater reduction in haemoglobin A1c (HbA1c) levels than those who received placebo.